HRT Financial’s Avenue Therapeutics ATXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-616
Closed -$6K – 3301
2024
Q1
$6K Buy
616
+279
+83% +$3.3K ﹤0.01% 2107
2023
Q4
$4K Buy
+337
New +$7.88K ﹤0.01% 2147
2022
Q3
– Sell
-35
Closed -$10K – 3649
2022
Q2
$10K Buy
+35
New +$13.5K ﹤0.01% 2685
2021
Q4
– Sell
-18
Closed -$29K – 4260
2021
Q3
$29K Sell
18
-4
-18% -$8.26K ﹤0.01% 3119
2021
Q2
$61K Buy
+22
New +$109K ﹤0.01% 2663

Other funds holding ATXI

HRT Financial's ATXI Position: Q2 2024 in Review

HRT Financial sold out of Avenue Therapeutics (ATXI) in Q2 2024, closing a stake of 616 shares — an estimated $6K sold.

HRT Financial first reported a position in ATXI in Q2 2021 and held it in 5 quarters. The position peaked at $61K in Q2 2021. 9 funds tracked by Wall St. Rank hold ATXI as of Q2 2024.

  • HRT Financial reported no remaining Avenue Therapeutics position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 616 Avenue Therapeutics shares in Q2 2024, an estimated $6K.
  • HRT Financial first reported a position in Avenue Therapeutics in Q2 2021 and held it in 5 quarters.
  • HRT Financial's Avenue Therapeutics position peaked at $61K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Avenue Therapeutics as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.